Aragon Pharmaceuticals, Inc v. Hetero Labs Limited Unit V

Court

District Court, D. New Jersey (D.N.J.)
Official Court Website →

Assigned judge

Stanley R. Chesler · 3,374 cases in index

Docket number

2:25-cv-11924

Cause

28:1338 Patent Infringement
28 U.S.C. § 1338 — Patent, copyright & trademark jurisdiction

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

06/18/2025

623 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Aragon Pharmaceuticals, Inc · 6 cases
• defendant · Hetero Labs Limited Unit V · 2 cases

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Aragon Pharmaceuticals, Inc v. Hetero Labs Limited Unit V?

Aragon Pharmaceuticals, Inc v. Hetero Labs Limited Unit V is a federal patent - anda lawsuit filed on 06/18/2025 in the District Court, D. New Jersey. The case is currently open in the federal court system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. New Jersey, docket number 2:25-cv-11924.

When was the case filed?

Aragon Pharmaceuticals, Inc v. Hetero Labs Limited Unit V was filed on 06/18/2025. The case is currently open.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 1338 — Patent, copyright & trademark jurisdiction.